CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-05 | Foff Erin Pennock Chief Medical Officer | Grant or award | +13,360 | 403,835 | ||
| 2026-02-05 | Foff Erin Pennock Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +54,240 | 54,240 | ||
| 2026-02-05 | Hanson Kristopher General Counsel | Grant or award | +7,730 | 191,582 | ||
| 2026-02-05 | Hanson Kristopher General Counsel | Grant or award · Employee Stock Option (right to buy) | +31,395 | 31,395 | ||
| 2026-02-05 | Lillie James Woodruff Chief Scientific Officer | Grant or award | +7,730 | 298,862 | ||
| 2026-02-05 | Lillie James Woodruff Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +31,395 | 31,395 | ||
| 2026-02-05 | GILLIS JONATHAN CAAO and PAO | Grant or award | +6,020 | 254,523 | ||
| 2026-02-05 | GILLIS JONATHAN CAAO and PAO | Grant or award · Employee Stock Option (right to buy) | +24,455 | 24,455 | ||
| 2026-02-05 | Kroeger Christopher A. Chief Executive Officer | Grant or award | +23,145 | 1,649,751 | ||
| 2026-02-05 | Kroeger Christopher A. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +93,955 | 93,955 | ||
| 2026-02-03 | Malenka Robert C. Director | Sale | −1 | $18.00 | $18 | 358,233 |
| 2026-02-02 | Malenka Robert C. Director | Sale | −7,039 | $18.02 | $127K | 358,234 |
| 2026-01-30 | Malenka Robert C. Director | Sale | −6,612 | $18.11 | $120K | 365,273 |
| 2026-01-29 | Malenka Robert C. Director | Sale | −21,262 | $18.55 | $394K | 371,885 |
| 2026-01-28 | Malenka Robert C. Director | Sale | −5,860 | $18.61 | $109K | 393,811 |
| 2026-01-28 | Malenka Robert C. Director | Sale | −664 | $19.05 | $13K | 393,147 |
| 2026-01-27 | Setia Vishwas Chief Financial Officer | Shares withheld for taxes | −33,382 | $17.98 | $600K | 387,819 |
| 2026-01-27 | Kreitzer Anatol Chief Discovery Officer | Shares withheld for taxes | −42,099 | $17.98 | $757K | 253,908 |
| 2026-01-27 | Foff Erin Pennock Chief Medical Officer | Shares withheld for taxes | −44,616 | $17.98 | $802K | 390,475 |
| 2026-01-27 | Hanson Kristopher General Counsel | Shares withheld for taxes | −26,007 | $17.98 | $468K | 183,852 |
Page 10 of 12 · 239 trades